Synovial type (group II) phospholipase A2 in cartilage

Area of Science:

• Biochemistry
• Immunology
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is characterized by inflammation in the synovial fluid.
• Phospholipase A2 (PLA2) activity in synovial fluid is implicated in RA pathogenesis.
• The specific cellular origin of synovial PLA2 (syn-PLA2) in RA remains unclear.

Purpose of the Study:

• To produce recombinant synovial PLA2 (syn-PLA2) using a synthetic gene.
• To generate specific polyclonal antibodies against syn-PLA2.
• To investigate the cellular localization of syn-PLA2 in human tissues, particularly cartilage and synovial tissue.

Main Methods:

• Recombinant expression of syn-PLA2 in E. coli.
• Production and isolation of rabbit polyclonal IgG antibodies against syn-PLA2.
• Specificity testing of antibodies using immunoblotting with cartilage extracts and purified PLA2.
• Immunohistochemical analysis of syn-PLA2 distribution in articular and extraarticular cartilage, synovial tissue, and other human tissues.

Main Results:

• Recombinant syn-PLA2 was successfully produced.
• Specific antibodies detected a 15 kDa protein in cartilage extracts, distinct from pancreatic or ascitic fluid PLA2.
• Immunohistochemistry revealed syn-PLA2 in chondrocytes and the matrix of articular, laryngeal, and auricular cartilage.
• Syn-PLA2 was not detected in synovial tissue or inflammatory cells from RA patients, nor in other tested human tissues.

Conclusions:

• Synovial PLA2 (syn-PLA2) is present in both articular and extraarticular cartilage.
• Chondrocytes are identified as a likely source of syn-PLA2 found in synovial fluid.
• These findings suggest that syn-PLA2 in RA patients originates from cartilage, not from synovial lining or inflammatory cells.